4Filing Date: Aug 17, 2026

Axon Enterpri

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001628280-26-057442
Total Value$0
Trades1
Insiders1

Transaction Details

Coughlin Elizabeth Reid
Chief Human Officer·Direct
Grant · Acquire
Common Stock
Shares+6.82K
Price$0.00
Total Value$0
Shares Owned After40.84K
Transaction DateAug 16, 2026
Footnotes ▸

The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted on December 22, 2023 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions for the fourth tranche of XSUs (the "Tranche") were certified by the issuer's Compensation Committee of the Board of Directors on August 16, 2026 as having been met. The Tranche will vest on December 1, 2026, subject to continued employment through such date. Following the vesting, the shares deliverable for the Tranche are subject to a minimum holding period until the earlier of (i) December 31, 2030 and (ii) the date on which a subsequent tranche of XSUs vests, excluding shares withheld or sold to cover applicable taxes.

Post-Transaction Holdings

Coughlin Elizabeth Reid · Chief Human Officer
SecuritySharesChange
Common Stock40.84K+6.82K (20.04%)
auto_awesome

Deep Analysis

Axon CHRO Coughlin collects 6,818 performance RSUs after certification of Tranche 4 — no shares sold.

lock
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-08-16 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: AXON ENTERPRISE, INC. (AXON) CIK: 0001069183 --- Reporting Owner --- Name: Coughlin Elizabeth Reid CIK: 0002104461 Role: Officer (Chief Human Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-08-16 | Code: A (Grant or award) Shares: +6,818 | Price: $0.00 Shares Owned After: 40,841.833 | Ownership: D (Direct) Footnotes: [F1] The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted on December 22, 2023 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions for the fourth tranche of XSUs (the "Tranche") were certified by the issuer's Compensation Committee of the Board of Directors on August 16, 2026 as having been met. The Tranche will vest on December 1, 2026, subject to continued employment through such date. Following the vesting, the shares deliverable for the Tranche are subject to a minimum holding period until the earlier of (i) December 31, 2030 and (ii) the date on which a subsequent tranche of XSUs vests, excluding shares withheld or sold to cover applicable taxes. --- Footnotes (Complete Index) --- F1: The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted on December 22, 2023 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions for the fourth tranche of XSUs (the "Tranche") were certified by the issuer's Compensation Committee of the Board of Directors on August 16, 2026 as having been met. The Tranche will vest on December 1, 2026, subject to continued employment through such date. Following the vesting, the shares deliverable for the Tranche are subject to a minimum holding period until the earlier of (i) December 31, 2030 and (ii) the date on which a subsequent tranche of XSUs vests, excluding shares withheld or sold to cover applicable taxes. --- Signature --- /s/ /s/ Elizabeth Reid Coughlin, by Isaiah Fields, Attorney-in-Fact (2026-08-17)

keid analysis is for reference only and does not constitute investment advice.